Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'pi3 kinase p110'

Search results for: 'pi3 kinase p110'

Items 521-530 of 692

Page
per page
  1. PRN694
    BA8983 PRN694
    Summary: PRN694 is an irreversible, highly potent and selective, potent covalently bound dual inhibitor of interleukin 2-inducible cell kinase, resting lymphocyte kinase.
  2. SKLB610
    A8237 SKLB610
    Summary: Potent VEGFR inhibitor
      insoluble in H2O; ≥20.75 mg/mL
  3. IRAK inhibitor 4
    A3503 IRAK inhibitor 4
    Target: IRAK
    Summary: IRAK inhibitor
      Soluble in DMSO
  4. Necrostatin 2
    A3652 Necrostatin 2
     2 Citation
    Summary: In vitro necroptosis inhibitor
      Soluble in DMSO
  5. UCN-01
    C4783 UCN-01
    Summary: inhibitor of Akt, protein kinase C, PDK1 and cyclin-dependent kinases
      Soluble in DMSO
  6. AG-1557
    C5417 AG-1557
    Summary: inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase
      ≤0.5 mg/mL
  7. CFI-400945
    C5813 CFI-400945
    Summary: orally available, selective inhibitor of polo-like kinase 4 (PLK4)
      insoluble in H2O; ≥109.8 mg/mL
  8. KN-93 Phosphate
    B4969 KN-93 Phosphate
    Target: Ca2 /calmodulin-dependent protein kinases (CaMKs)
    Summary: CaM kinase II inhibitor, water soluble and cell permeable
      ≥29.95 mg/mL
  9. Autocamtide-2-related inhibitory peptide
    B6831 Autocamtide-2-related inhibitory peptide
    Target: Ca2 /calmodulin-dependent protein kinases (CaMKs)
    Summary: inhibitor of calmodulin-dependent protein kinase II (CaM-kinase II, CaMKII)
      ≥40.2 mg/mL
  10. Src I1
    B7452 Src I1
    Summary: competitive dual site (ATP- and peptide-binding) Src kinase inhibitor
      Soluble in DMSO

Items 521-530 of 692

Page
per page
Shop By
Shopping Options
Category
  1. Signaling Pathways330item
  2. Kits2item
  3. Screening Library7item
  4. Peptides3item
  5. Peptides & Proteins10item
  6. Antibody44item
  7. Biochemical Reagent291item
Specificity
  1. Selective117item
Reversibility
  1. Reversible10item
  2. Irreversible3item
Target
  1. Cyclin-Dependent Kinases18item
  2. Akt1 item
  3. PI3K2item
  4. Raf4item
  5. Aurora Kinases20item
  6. CSF-1R3item
  7. FLT36item
  8. PLK2item
  9. Chk1 item
  10. Eph Receptors1 item
  11. VEGFR11item
  12. PDGFR7item
  13. c-Kit4item
  14. RET3item
  15. IRAK3item
  16. p384item
  17. PKB1 item
  18. JNK1 item
  19. Bcr-Abl5item
  20. MEK2item
  21. FGFR3item
  22. Pim4item
  23. Ribosomal s6 kinases (RSK)1 item
  24. MET2item
  25. Src9item
  26. Trk Receptors1 item
  27. STAT1 item
  28. EGFR6item
  29. ROCK3item
  30. BMP and Other Activin Receptors1 item
  31. JAK7item
  32. Syk4item
  33. DNA-PK1 item
  34. Adenosine Kinases2item
  35. PKC4item
  36. Ca2 /calmodulin-dependent protein kinases (CaMKs)4item
  37. Lyn1 item
  38. HER21 item
  39. LRRK23item
  40. Insulin and Insulin-like Receptors1 item
  41. ALK1 item
  42. ROS11 item
  43. PKG1 item
  44. PKA2item
  45. Myosin light chain kinases (MLCKs)2item
  46. CaM-KK1 item
  47. MELK1 item
  48. Clk1 item
  49. Angiotensin-Converting Enzymes (ACEs)1 item
  50. Tie-22item
  51. ATM/ATR3item
  52. CK11 item
  53. CK21 item
  54. HIPK21 item
  55. HIPK31 item
  56. P2X Receptors1 item
  57. TAK11 item
  58. Hck1 item
  59. 5-Lipoxygenases1 item
  60. Cdc2-like kinase (Clk)1 item
  61. eEF-21 item
  62. ZAP-701 item
  63. c-RET1 item
  64. p70 rsk2item
  65. VEGFR3/FLT41 item
  66. NTRK1/TRKA1 item
  67. CSF-1R/c-Fms1 item
  68. TAM kinase1 item
  69. Fyn kinase1 item
  70. AXL1 item
  71. c-Fms tyrosine kinase1 item
  72. haspin kinase1 item
  73. STK1 item
  74. Lyn kinase1 item
  75. Mer tyrosine kinase1 item
  76. Histone Acetyltransferases (HATs)1 item
  77. ITK1 item
  78. NUAK1 item
  79. DCLK21 item
  80. PTK1 item
  81. Lck1 item
  82. FGR1 item
  83. YES1 item
  84. Fyn1 item
  85. ARG1 item
  86. enoyl-acyl-carrier protein reductase1 item
  87. SK1 item
  88. ATM1 item
  89. Insulin Receptor1 item
Reported Experiments
  1. Animal Experiments119item
  2. Cell Experiments89item
Related Disease
  1. Acute Myeloid Leukemia9item
  2. Adrenocortical Carcinoma1 item
  3. Advanced Renal Cell Carcinoma1 item
  4. Bladder Cancer2item
  5. Bladder Carcinoma1 item
  6. B-lymphoid Malignancies1 item
  7. Breast Cancer23item
  8. Cancer90item
  9. Cervical Cancer2item
  10. Cholangiocarcinoma1 item
  11. Chronic Lymphocytic Leukemia1 item
  12. Colon Cancer11item
  13. Colon Carcinoma1 item
  14. Colorectal Cancer6item
  15. Glioblastoma7item
  16. Glioma4item
  17. Hepatocellular Carcinoma1 item
  18. Immunological Diseases1 item
  19. Inflammatory Bowel Disease1 item
  20. Inflammatory Diseases3item
  21. Leukemia3item
  22. Liver Cancer2item
  23. Lung Cancer6item
  24. Lung Carcinoma1 item
  25. Lymphoma6item
  26. Mantle Cell Lymphoma1 item
  27. Melanoma5item
  28. Multiple Myeloma3item
  29. Neuroblastoma1 item
  30. Non-small Cell Lung Cancer1 item
  31. Ovarian Cancer9item
  32. Pancreatic Cancer10item
  33. Prostate Cancer5item
  34. Renal Cancer1 item
  35. Renal Cell Carcinoma2item
  36. Rheumatoid Arthritis3item
  37. Thyroid Cancer5item